dc.contributor.author | Vandenbunder, B | fr_FR |
dc.date.accessioned | 2013-02-12T12:51:13Z | |
dc.date.available | 2013-02-12T12:51:13Z | |
dc.date.issued | 1995 | fr_FR |
dc.identifier.citation | Vandenbunder, B, Repenser les oncogènes en 1995 ?, Med Sci (Paris), 1995, Vol. 11, N° 10; p.1465-70 | fr_FR |
dc.identifier.issn | 1958-5381 | fr_FR |
dc.identifier.uri | http://hdl.handle.net/10608/2331 | |
dc.language.iso | fr | fr_FR |
dc.publisher | John Libbey Eurotext, Montrouge | fr_FR |
dc.rights | Article en libre accès | fr |
dc.rights | Médecine/Sciences - Inserm - SRMS | fr |
dc.source | M/S. Médecine sciences [revue papier, ISSN : 0767-0974], 1995, Vol. 11, N° 10; p.1465-70 | fr_FR |
dc.title | Repenser les oncogènes en 1995 ? | fr |
dc.type | Article | fr_FR |
dc.identifier.doi | 10.4267/10608/2331 | |